On the other hand, ZIP10 mRNA expression in patients with myelodysplastic neoplasms (MDS) (n = 206)—a disease that predisposes individuals to the development of AML—was not increased compared to healthy subjects (n = 73) (Figure S3F). Here, SLC39A10 is linked to myelodysplastic syndrome.